Bayer Doles Out $1M of Its PHAB Awards to 7 Research Projects

Bayer Doles Out $1M of Its PHAB Awards to 7 Research Projects

305776

Bayer Doles Out $1M of Its PHAB Awards to 7 Research Projects

As part of the company’s Pulmonary Hypertension Accelerated Bayer (PHAB) Awards, Bayer is giving a total of $1 million to seven research projects related to pulmonary hypertension. The awards are aimed at projects focused on pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH), which makes the PHAB Awards one of the largest industry-funded grant programs focused on these types of pulmonary hypertension in the U.S., according to Bayer. Applications for the 2021 PHAB Awards are open…

You must be logged in to read/download the full post.